Shufro Rose & CO LLC Abb Vie Inc. Transaction History

Shufro Rose & CO LLC

$1.2 Billion
Q1 2024

A detailed history of Shufro Rose & CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Shufro Rose & CO LLC holds 3,395 shares of ABBV stock, worth $585,026. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,395

Previous 3,095 9.69%

Holding current value

$585,026

Previous $479,000 29.02%

% of portfolio

0.05%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $47,946 - $54,630	300 Added 9.69%	3,395 $618,000
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $21,507 - $24,898	-161 Reduced 4.94%	3,095 $461,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $28,922 - $33,308	-200 Reduced 5.79%	3,256 $518,000
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $1,244 - $1,492	-9 Reduced 0.26%	3,456 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $202,522 - $232,280	1,509 Added 77.15%	3,465 $465,000

Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $13,762 - $17,496	100 Added 5.39%	1,956 $300,000
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $12,406 - $15,392	-94 Reduced 4.82%	1,856 $301,000
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $7,022 - $7,971	-66 Reduced 3.27%	1,950 $210,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $7.92 Million - $8.82 Million	-75,240 Reduced 97.39%	2,016 $227,000
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $513,443 - $565,239	-5,019 Reduced 6.1%	77,256 $8.36 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $280,024 - $378,062	-3,479 Reduced 4.06%	82,275 $8.82 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $521,130 - $611,634	-6,066 Reduced 6.61%	85,754 $7.51 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $6.74 Million - $9.01 Million	91,820 New	91,820 $9.02 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $188,662 - $286,035	-2,925 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $72,130 - $90,250	-1,000 Reduced 25.48%	2,925 $259,000
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $3,211 - $3,861	-51 Reduced 1.28%	3,925 $297,000
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $69,050 - $88,262	1,051 Added 35.93%	3,976 $289,000
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $7,784 - $9,601	100 Added 3.54%	2,925 $270,000
Q3 2018 Oct 26, 2018	BUY	$88.91 - $98.84 $31,118 - $34,594	350 Added 14.14%	2,825 $267,000
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $28,729 - $33,993	320 Added 14.85%	2,475 $229,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 4.43%	2,155 $204,000
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $42,541 - $46,649	-475 Reduced 17.4%	2,255 $218,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $190,690 - $243,570	2,730	2,730 $243,000

Others Institutions Holding ABBV

# of Institutions

3,650

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $305B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Account

Shufro Rose & CO LLC Abb Vie Inc. Transaction History